[1]
2025. Formulation Development, Characterization, And Optimization Of Teneligliptin-Embedded Transdermal Patches For The Management Of Diabetes Mellitus. Vascular and Endovascular Review. 8, 20s (Dec. 2025), 10–18. DOI:https://doi.org/10.64149/J.Ver.8.20s.10-18.